Deakin University
Browse
- No file added yet -

Opioid analgesia and opioid-induced adverse effects: A review

Download (3.32 MB)
Version 3 2024-06-19, 06:23
Version 2 2024-06-03, 07:07
Version 1 2021-11-01, 14:07
journal contribution
posted on 2024-06-19, 06:23 authored by AK Paul, Craig SmithCraig Smith, M Rahmatullah, V Nissapatorn, P Wilairatana, M Spetea, N Gueven, N Dietis
Opioids are widely used as therapeutic agents against moderate to severe acute and chronic pain. Still, these classes of analgesic drugs have many potential limitations as they induce analgesic tolerance, addiction and numerous behavioural adverse effects that often result in patient non-compliance. As opium and opioids have been traditionally used as painkillers, the exact mechanisms of their adverse reactions over repeated use are multifactorial and not fully understood. Older adults suffer from cancer and non-cancer chronic pain more than younger adults, due to the physiological changes related to ageing and their reduced metabolic capabilities and thus show an increased number of adverse reactions to opioid drugs. All clinically used opioids are μ-opioid receptor agonists, and the major adverse effects are directly or potentially connected to this receptor. Multifunctional opioid ligands or peripherally restricted opioids may elicit fewer adverse effects, as shown in preclinical studies, but these results need reproducibility from further extensive clinical trials. The current review aims to overview various mechanisms involved in the adverse effects induced by opioids, to provide a better understanding of the underlying pathophysiology and, ultimately, to help develop an effective therapeutic strategy to better manage pain.

History

Journal

Pharmaceuticals

Volume

14

Article number

ARTN 1091

Pagination

1 - 22

Location

Switzerland

Open access

  • Yes

ISSN

1424-8247

eISSN

1424-8247

Language

English

Publication classification

C1 Refereed article in a scholarly journal

Issue

11

Publisher

MDPI